News & Articles
Selected Filters:
Abbott's 15-minute, $5 COVID-19 antigen test receives FDA emergency use authorization
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination
Next-generation remote monitoring solution supports uncompromised sample safety and integrity
The Thermo Scientific Smart-Vue Pro Remote Monitoring Solution protects samples, improves laboratory efficiency and facilitates regulatory compliance
Promega launches COVID-19 serology test: Lumit™ Dx SARS-CoV-2 Immunoassay
Workflow is quick, simple and scalable for high-throughput antibody detection with high PPA sensitivity and NPA specificity
Fluidigm granted EUA for saliva-based Advanta Dx SARS-CoV-2 RT-PCR assay
The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays
Maravai LifeSciences expands CleanCap mRNA capping capacity and new plasmid DNA manufacturing
Second manufacturing expansion will help meet global demand for research, clinical and GMP grade raw materials as well as research and clinical-grade APIs to include mRNA, self-amplifying RNA and plasmid DNA
Tracking COVID-19 ‘super spreading’ events with viral sequencing
Hear how one trailblazing lab at the Broad Institute of MIT and Harvard is using automated sample tracking to monitor pandemics such as Ebola Virus Disease and COVID-19
Dotmatics announce the release of Bioregister 2020.1
Supports cross-functional teams of chemists and biologists developing non-natural, chemically modified therapeutics for drug discovery
Discovery of new genes that influence the success of cancer treatment
Researchers at the University of Bern have now discovered which genes play an important role in the response to radiation therapy
Cambridge-developed SARS-CoV-2 vaccine receives £1.9million from UK government for clinical trial
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK as early as autumn, thanks to a £1.9million award from the UK government
IsoPlexis adds partnership to advance COVID-19 vaccine development
The overall goal is to continue to detect and discover critical components in the overall cellular response to COVID-19
QIAGEN expands integrated coronavirus NGS and software solutions
QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research
Luminex files for emergency use of expanded NxTAG Respiratory Panel test
Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season
PerkinElmer launches COVID-19 environmental surface testing kits
The new kits are based on the technology of the PerkinElmer New Coronavirus Nucleic Acid Detection Kit
Enhanced performance of nanoparticle-mediated drug delivery systems
A Presidential award-winning laboratory has developed a new technology to address one of the most pressing challenges in nanomedicine
T cell characterization combining advanced flow cytometry with live-cell analysis
Watch this on-demand webinar to gain insight on how advanced flow cytometry and live-cell analysis can facilitate faster drug development